Load more products Conclusion Starting a new medication is a big step toward better health, and dealing with an adjusting body is part of the process
The commentary concluded that, based on current knowledge, patients should not stop taking semaglutide on this account alone, especially given potential increases in morbidity from conditions that are well controlled by semaglutide, potential adverse effects of hyperglycemia caused by abrupt cessation of treatment, and the seemingly low absolute risk of NAION
These cells work together and communicate to influence each other's behavior, both under normal conditions and during inflammatory events
Legal and Regulatory Context It is important to understand why the availability of these options changes
Possible Side Effects And Risks Because the active ingredient in semaglutide glycine is still Semaglutide, the side effect profile generally mirrors what is seen with standard Semaglutide products